Michelle Hanna is the founder and CEO of Ribomed Biotechnologies, a six-year-old Phoenix-based molecular biology tools startup with approximately $5 million in grants to develop technology for a handheld bioterrorism agents detection device, and the developer of a new laboratory workspace located across the street from the Translational Genomics Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.